RedHill Biopharma Fundamental Relationships

RDHL -- Israel Stock  

ILS 264.00  3.90  1.50%

The Drivers Module shows relationships between RedHill Biopharma's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of RedHill Biopharma Ltd over time as well as its relative position and ranking within its peers. Additionally take a look at Your Equity Center.

RedHill Biopharma Return On Asset vs. Cash and Equivalents Fundamental Analysis

RedHill Biopharma Ltd is rated third in cash and equivalents category among related companies. It is rated fourth in return on asset category among related companies .
Cash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
RedHill Biopharma 
Cash 
 = 
Bank Deposits 
+  
Liquidities 
=
43.03M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually 3 months).
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
RedHill Biopharma 
Return on Asset 
 = 
Net Income 
Total Assets 
X
100 
=
(51.61)%
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

RedHill Biopharma Return On Asset Comparison

  Return On Asset 
      RedHill Biopharma Comparables 
RedHill Biopharma is currently under evaluation in return on asset category among related companies.
  Revenue 
      RedHill Biopharma Comparables 
RedHill Biopharma is currently under evaluation in revenue category among related companies.
Search macroaxis.com